EE200300138A - Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid - Google Patents

Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE200300138A
EE200300138A EEP200300138A EEP200300138A EE200300138A EE 200300138 A EE200300138 A EE 200300138A EE P200300138 A EEP200300138 A EE P200300138A EE P200300138 A EEP200300138 A EE P200300138A EE 200300138 A EE200300138 A EE 200300138A
Authority
EE
Estonia
Prior art keywords
pseudoephedrine
pharmaceutical compositions
compositions containing
containing epinastine
epinastine
Prior art date
Application number
EEP200300138A
Other languages
English (en)
Inventor
Abelaira Sara
Bianchi Daniel
Gel Francisco
Denker Victor
Fernandez Mabel
Cicconi De Vidal Marta
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200300138(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of EE200300138A publication Critical patent/EE200300138A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EEP200300138A 2000-10-06 2001-09-28 Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid EE200300138A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00121828 2000-10-06
PCT/EP2001/011229 WO2002028373A1 (en) 2000-10-06 2001-09-28 New pharmaceutical compositions containing epinastine and pseudoephedrine

Publications (1)

Publication Number Publication Date
EE200300138A true EE200300138A (et) 2003-08-15

Family

ID=8170029

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300138A EE200300138A (et) 2000-10-06 2001-09-28 Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid

Country Status (32)

Country Link
EP (1) EP1326586B1 (et)
JP (1) JP2004521864A (et)
KR (1) KR20030036894A (et)
CN (1) CN1291715C (et)
AR (2) AR032479A1 (et)
AT (1) ATE424813T1 (et)
AU (2) AU1229002A (et)
BG (1) BG107686A (et)
BR (1) BR0114339A (et)
CA (1) CA2423288C (et)
CZ (1) CZ2003945A3 (et)
DE (1) DE60137952D1 (et)
EA (1) EA007288B1 (et)
EC (1) ECSP034513A (et)
EE (1) EE200300138A (et)
ES (1) ES2323570T3 (et)
HK (1) HK1062196A1 (et)
HR (1) HRP20030259A2 (et)
HU (1) HUP0300970A3 (et)
IL (1) IL154884A0 (et)
ME (1) MEP39708A (et)
MX (1) MXPA03002900A (et)
MY (1) MY131159A (et)
NO (1) NO20031537L (et)
NZ (1) NZ525653A (et)
PE (1) PE20020324A1 (et)
PL (1) PL366123A1 (et)
SK (1) SK4052003A3 (et)
UA (1) UA75896C2 (et)
WO (1) WO2002028373A1 (et)
YU (1) YU24603A (et)
ZA (1) ZA200302079B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2450583A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
JP4549618B2 (ja) * 2001-11-22 2010-09-22 第一三共ヘルスケア株式会社 鼻炎用組成物
BR0313175A (pt) * 2002-08-02 2005-06-14 Boehringer Ingelheim Int Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
JP5021155B2 (ja) * 2003-08-01 2012-09-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物
US20070196396A1 (en) * 2004-02-11 2007-08-23 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DK1041990T3 (da) * 1997-12-23 2006-10-02 Schering Corp Præparat til behandling af respiratoriske sygdomme og hudsygdomme med mindst en leukotrien-antagonist og mindst et antihistamin
CN1329490A (zh) * 1998-10-09 2002-01-02 先灵公司 用于治疗变应性疾病的组合物和方法
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
EA200300430A1 (ru) 2003-10-30
CN1291715C (zh) 2006-12-27
HRP20030259A2 (en) 2005-02-28
PE20020324A1 (es) 2002-06-18
CA2423288C (en) 2007-11-13
CZ2003945A3 (cs) 2003-08-13
BR0114339A (pt) 2003-12-09
CA2423288A1 (en) 2002-04-11
AU1229002A (en) 2002-04-15
AR032479A1 (es) 2003-11-12
MXPA03002900A (es) 2003-09-10
NO20031537L (no) 2003-06-04
IL154884A0 (en) 2003-10-31
ATE424813T1 (de) 2009-03-15
NO20031537D0 (no) 2003-04-04
ZA200302079B (en) 2004-05-05
KR20030036894A (ko) 2003-05-09
EP1326586A1 (en) 2003-07-16
AU2002212290B2 (en) 2006-08-03
ECSP034513A (es) 2003-04-25
YU24603A (sh) 2006-05-25
EA007288B1 (ru) 2006-08-25
PL366123A1 (en) 2005-01-24
AR087240A2 (es) 2014-03-12
MEP39708A (en) 2011-02-10
HUP0300970A3 (en) 2005-03-29
SK4052003A3 (en) 2003-09-11
MY131159A (en) 2007-07-31
CN1468094A (zh) 2004-01-14
HUP0300970A2 (hu) 2003-11-28
UA75896C2 (en) 2006-06-15
WO2002028373A1 (en) 2002-04-11
ES2323570T3 (es) 2009-07-21
DE60137952D1 (de) 2009-04-23
EP1326586B1 (en) 2009-03-11
HK1062196A1 (en) 2004-10-21
JP2004521864A (ja) 2004-07-22
NZ525653A (en) 2006-07-28
BG107686A (bg) 2003-11-28

Similar Documents

Publication Publication Date Title
NO20025450L (no) Ny farmasöytisk sammensetning
DK1524266T3 (da) Farmaceutisk sammensætning
FI991485A (fi) Uusi farmaseuttinen koostumus
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
ITMI20010748A0 (it) Composizioni farmaceutiche
NO20005913L (no) Legemiddelsammensetning
ID27415A (id) Komposisi farmaseutik
EA199900373A3 (ru) Фармацевтические композиции
ID29262A (id) Komposisi farmasi
EE05020B1 (et) Glburiidi ravimkoostis
NO20026123L (no) Farmasöytiske sammensetninger
NO20031095L (no) Farmasoytiske sammensetninger
ITMI20011637A0 (it) Composizione farmaceutica contenente citalopram
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
EE200300138A (et) Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid
ID26215A (id) Komposisi farmasi
EE200200689A (et) Ravimkoostised
FR2797401B1 (fr) Composition pharmaceutique anti-ulcere et sa preparation
SE9803771D0 (sv) Pharmaceutical composition and use
SE9904414D0 (sv) Pharmaceutical composition and use
SE0004405D0 (sv) New composition and use
DK200100203U4 (da) Farmaceutisk komposition indeholdende citalopram